ε-Polylysine hydrochloride as drug excipient

ε-Polylysine hydrochloride has extensive applications in the field of pharmaceutical excipients. It is a novel antimicrobial agent with broad-spectrum antimicrobial properties and high safety. Therefore, it has great potential for use in food preservation. Additionally, ε-Polylysine hydrochloride plays an important role in the preparation of preventive and/or therapeutic antitumor drugs, especially in the preparation of drugs for preventing and/or treating human liver cancer and human colon cancer. Relevant anti-cancer activity experiments have shown that ε-polylysine hydrochloride has good inhibitory effects on cancer cells, comparable to some commonly used drugs.

Furthermore, ε-polylysine hydrochloride also finds applications in the field of functional factor carrier preparation. For example, through specific preparation steps, it can be combined with natural fatty acid salt hydrogels to prepare a gel material with better functionality.

Although the applications of ε-polylysine hydrochloride in the above-mentioned fields have been widely researched and recognized, its specific application methods and effects as pharmaceutical excipients may still require further in-depth research and verification based on the specific types of drugs and preparation processes.

While ε-polylysine hydrochloride has many advantages as a pharmaceutical excipient, strict adherence to relevant regulations and standards is still necessary to ensure the safety and effectiveness of drugs in practical applications. For new application methods and effects, sufficient scientific research and clinical trials are also required to verify their safety and effectiveness.